COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge
- PMID: 32516940
- PMCID: PMC7356953
- DOI: 10.3390/jcm9061753
COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge
Abstract
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide concern. SARS-CoV-2 has spread to 210 countries worldwide and more than 6,500,000 confirmed cases and 384,643 deaths have been reported, while the number of both confirmed and fatal cases is continually increasing. COVID-19 is a viral disease that can affect every age group-from infants to the elderly-resulting in a wide spectrum of various clinical manifestations. COVID-19 might present different degrees of severity-from mild or even asymptomatic carriers, even to fatal cases. The most common complications include pneumonia and acute respiratory distress syndrome. Fever, dry cough, muscle weakness, and chest pain are the most prevalent and typical symptoms of COVID-19. However, patients might also present atypical symptoms that can occur alone, which might indicate the possible SARS-CoV-2 infection. The aim of this paper is to review and summarize all of the findings regarding clinical manifestations of COVID-19 patients, which include respiratory, neurological, olfactory and gustatory, gastrointestinal, ophthalmic, dermatological, cardiac, and rheumatologic manifestations, as well as specific symptoms in pediatric patients.
Keywords: Coronavirus disease 2019 (COVID-19); RNA; coronavirus; diagnosis; epidemic; outbreak; pandemics; public health; symptoms; the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization (WHO) Statement on the Second Meeting of the International Health Regulations Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) WHO; Geneva, Switzerland: 2005. [(accessed on 30 January 2020)]. Available online: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...
-
- World Health Organisation . WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11. WHO; Geneva, Switzerland: 2020. [(accessed on 12 March 2020)]. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
-
- Setti L., Passarini F., De Gennaro G., Barbieri P., Pallavicini A., Ruscio M., Piscitelli P., Colao A., Miani A. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Int. J. Environ. Res. Public Health. 2020;17:2986. doi: 10.3390/ijerph17092986. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
